An estimated 2 million adolescents ages 10 to 19 are living with HIV, with 86 percent of them from sub-Saharan Africa, according to a global report on HIV prevention launched in Johannesburg on Wednesday.…

Scientists on Thursday blamed Europe's worst recorded food-poisoning outbreak on a super-toxic strain of E. coli bacteria that might be brand new. But while suspicion has fallen on rawtomatoes, cucumbers and lettuce.…

Cause And Potential Treatment Found For Cancer Drug's Kidney Toxicity Scientists may have a way to make the powerful cancerdrug cisplatin less toxic to the kidneys and more effective against some cancers. …

An outbreak of E. coli infection was detected in Germany about two weeks ago. Health authorities say that over 1500 people have become infected and 17 have died so far. Cases of E. coli infection have been reported in several other countries.…

A collaboration of Miller School physicians, surgeons and scientists has unlocked the mechanism of a drug used to prevent recurrent kidney disease. The finding, which has implications for the diagnosis and treatment of many other diseases.…

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. …

(Reuters) - A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday. …

A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows. The drug Cabozantinib is designed to targetmainly two important pathways linked to the growth.…

THURSDAY, June 9 (HealthDay News) -- The U.S. Food and Drug Administration is calling for new warning labels on a class of drugs used primarily to treat enlarged prostates, because the medications may raise the risk of prostate cancer.…

Research by male cancer campaign, Everyman, found that nearly three quarters of men surveyedwere unable to name age, family history or race as the top risk factors for prostate cancer,while a quarter admitted having no knowledge of any risk factors.…